Purdue Pharma L.P.
Case Number:
7:19-bk-23649
Court:
Nature of Suit:
Firms
- Blitman & King
- Bielli & Klauder
- Doster Ullom
- Tarter Krinsky
- Teitelbaum Law Group
- Simmons Hanly
- Stevens & Lee
- Godfrey & Kahn
- Pillsbury Winthrop
- Gilbert LLP
- Himes Petrarca
- Lowe Stein
- Skadden Arps
- Seyfarth Shaw
- Wachtell Lipton
- Archer & Greiner
- Porter Hedges
- Gage Spencer & Fleming
- ArentFox Schiff
- Dentons
- Kirkland & Ellis
- Consovoy McCarthy
- Kobre & Kim
- Morgan Lewis
- Gertz & Rosen
- Porteous Hainkel
- Crowell & Moring
- Troutman
- Andrews & Thornton
- Bentley & Bruning
- ASK LLP
- Willkie Farr
- Joseph Hage
- Potter Anderson
- Spangenberg Shibley
- Cuneo Gilbert
- White & Case
- Motley Rice
- Mintz Levin
- WestLoop Law
- Arnold & Porter
- Miller Nash LLP
- McDermott Will & Schulte
- McGrail & Bensinger
- Taft Stettinius
- Cronin Fried
- Loeb & Loeb
- Cleary Gottlieb
- Jones Day
- Robins Kaplan
- MoloLamken
- Faegre Drinker
- Duane Morris
- Foley & Lardner
- Reed Smith
- Slevin & Hart
- Doshi Legal Group
- Hogan Lovells
- Shook Hardy
- Goodwin Procter
- Schenck Price
- Pachulski Stang
- Lerner Arnold
- Bialson Bergen
- Martin S. Rapaport
- Brown Rudnick
- Marino Tortorella
- Saul Ewing
- Davis Polk
- BatesCarey
- Burke Warren
- King & Spalding
- Wilk Auslander
- Stutzman Bromberg
- WilmerHale
- Phillips Lytle
- Brown & Connery
- Hagens Berman
- Napoli Shkolnik
- Marcus & Shapira
- Quinn Emanuel
- Squire Patton
- Shafferman & Feldman
- Ballard Spahr
- Hughes Socol
- Keller Rohrback
- O'Melveny & Myers
- Blank Rome
- Keller Postman
- Kleinberg Kaplan
- Katsky Korins
- Clifford Law Offices
- Barack Ferrazzano
- Terrell Hogan
- Sherrard Roe
- Levenfeld Pearlstein
- Rothstein Mandell
- Debevoise & Plimpton
- MacElree Harvey
- Pashman Stein
- Hurwitz Fine
- Pullman & Comley
- Mehri & Skalet
- Tate Law Group LLC
- Klehr Harrison
- Frost Brown
- Lowey Dannenberg
- Williams Mullen
- UB Greensfelder
- Waldrep Wall
- Dechert LLP
- Ifrah Law
- Seward & Kissel
- Simpson Thacher & Bartlett LLP
- Calfee Halter
- White Coleman & Associates
- Caplin & Drysdale
- Miller Shah
- O'Brien Belland
- Binder & Schwartz
- Alston & Bird
- Akin Gump
- Carter Ledyard
- Shipman & Goodwin
- McElroy Deutsch
- Henrichsen Law Group
- Jenner & Block
- Haug Partners
- HSF Kramer
- Hobbs Straus
- Latham & Watkins
- Mayer Brown
- Milbank LLP
Companies
- Teamsters Local 456
- Henry Schein Inc.
- Sun Pharmaceutical Industries Ltd.
- Hikma Pharmaceuticals PLC
- Walmart Inc.
- McKesson Corp.
- Otis Worldwide Corp.
- Impax Laboratories, Inc.
- Johnson & Johnson
- Kodiak Area Native Association
- Ranbaxy
- Tucson Medical Center
- PRA Health Sciences Inc.
- Ascent Pharmaceuticals Inc.
- Blue Cross Blue Shield Association
- Aleutian Pribilof Islands Association Inc.
- Collegium Pharmaceutical Inc.
- Endo International PLC
- Omnicare Inc.
- Giant Eagle Inc.
- Bausch Health Cos. Inc.
- Province LLC
- United Parcel Service Inc.
- Sandoz International GmbH
- Avrio Health LP
- Nardello & Co. LLC
- Cencora Inc.
- Express Scripts Holding Co.
- Hain Capital Group LLC
- KVK Tech Inc.
- Amneal Pharmaceuticals Inc.
- Loblaw Cos.
- TR Capital Management LLC
- The Cigna Group
- Ironshore Inc.
- Noramco Inc.
- Alaska Native Tribal Health Consortium
- Anda Inc.
- AlixPartners LLP
- AXA XL Ltd.
- Allergan PLC
- Purdue Pharma LP
- CVS Health Corp.
- United Food & Commercial Workers International Union
- Viatris Inc.
- FTI Consulting Inc.
- ASM Capital LP
- SAP AG
- Apria Healthcare Group
- Cardinal Health Inc.
- Liberty Mutual Insurance Group
- Bristol-Myers Squibb Co.
- Arcadia Consumer Healthcare
- International Union Of Operating Engineers
- DuPont de Nemours Inc.
- Old Republic Insurance Co.
- Oracle Corp.
- Thermo Fisher Scientific Inc.
- Verita Global LLC
- Houlihan Lokey Inc.
- American Federation of Labor & Congress of Industrial Organizations
- Jefferies Financial Group Inc.
- Teva Pharmaceutical Industries Ltd.
Government Agencies
- Seldovia Village Tribe
- Pension Benefit Guaranty Corp.
- Missouri Department of Revenue
- Pala Band of Mission Indians
- U.S. District Court for the District of Columbia
- Town of Ramapo, New York
- City of Bayonne, New Jersey
- Commonwealth of Massachusetts
- State of Nevada
- Washington State Department of Revenue
- Nez Perce Tribe
- Port Gamble S'Klallam Tribe
- Borough of Paramus, New Jersey
- Jamestown S'Klallam Tribe
- Northwestern Band of the Shoshone Nation
- St. Regis Mohawk Tribe
- Town of Babylon, New York
- Town of Brookhaven, New York
- New York Department of Financial Services
- Town of Hempstead, New York
- State of Indiana
- Hopi Tribe
- Tennessee Attorney General's Office
- Suquamish Tribe
- Ohio Attorney General's Office
Sectors & Industries:
-
October 21, 2025
Purdue Touts Wide Support For Latest Ch. 11 Plan
Pharmaceutical titan Purdue Pharma heralded Tuesday that its newest Chapter 11 plan has almost total support from voting creditors, saying the proposal could pave the way to creditors receiving more than $7 billion, after its well-publicized role in the opioid epidemic pushed the company into bankruptcy and the U.S. Supreme Court rejected its original plan.
-
October 17, 2025
What's Happening In Bankruptcy Court This Coming Week
Village Roadshow's third proposed sale will go before a judge. A bankruptcy court will consider confirming Heritage Coal's liquidation plan. And a CVS Health subsidiary will seek final approval of its bankruptcy financing.
-
September 22, 2025
Rite Aid Can Seek Plan Votes, Purdue CEO Bonus Approved
A New Jersey bankruptcy judge gave Rite Aid the go-ahead to solicit Chapter 11 plan votes. A New York bankruptcy judge gave permission for Purdue Pharma to offer its chief executive a nearly $3 million incentive package. And a Delaware judge approved fiber network developer Tilson Technology Management Inc.'s asset sale to ITG Communications LLC.
-
September 17, 2025
Purdue Can Pay CEO Ch. 11 Bonus After Trimming Comp
A New York bankruptcy judge Wednesday approved a nearly $3 million incentive program for Purdue Pharma's chief executive after he agreed to reduce his total compensation by $500,000.
-
September 12, 2025
What's Happening In Bankruptcy Court This Coming Week
Purdue will ask a bankruptcy court to approve a retention incentive package for its CEO. Tilson Technology is scheduled for a hearing on its request for permission to complete a proposed asset sale. And the judge overseeing Steward Health Care's bankruptcy will consider whether to compel two hospital buyers to make payments and defend against accusations of contempt.
-
September 08, 2025
NY Diocese Wins OK Of Ch. 11 Plan, Yellow Nears Approval
A New York judge authorized the Chapter 11 plan of the Roman Catholic Diocese of Rochester, Yellow Corp.'s newest bankruptcy plan disclosure statement won tentative approval, and Monster.com was given the go-ahead to begin collecting votes on a Chapter 11 plan. This is the week in bankruptcy.
-
September 04, 2025
Purdue Pharma Approved For $17.5M In Ch. 11 Bonus Plans
Bankrupt pharmaceutical company Purdue Pharma LP received approval from a New York judge Thursday to pay more than $17.5 million in employee bonuses, mirroring the bonus structures of the last few years since the company commenced its Chapter 11 case.
-
August 29, 2025
What's Happening In Bankruptcy Court This Coming Week
A New York bankruptcy court will consider letting Purdue Pharma collaborate with a nonprofit on a cancer drug. A Delaware bankruptcy judge is slated to hear Monster.com's bid to begin soliciting votes on a Chapter 11 plan. And another bankruptcy judge in Delaware will weigh whether to grant interim approval for the combined plan and disclosure of Heritage Coal's owner.
-
August 20, 2025
Purdue Asks Bankruptcy Court To OK Drug Trial Collaboration
Purdue Pharma LP asked a New York bankruptcy court to allow it to enter a clinical trial collaboration with a nonprofit, saying that doing so would allow Purdue to continue developing a potential treatment for a deadly brain cancer while restraining costs.
-
July 31, 2025
Purdue Government Group Gets OK To Hire Claims Admin
A New York bankruptcy judge Thursday gave an ad hoc governmental group permission to hire an administrator to handle claims in Purdue Pharma's $8 billion Chapter 11 plan, saying the administrator's services are needed.